Shanghai General Healthy Information and Technology Second Quarter 2024 Earnings: EPS: CN¥0.18 (vs CN¥0.35 in 2Q 2023)

Simply Wall St · 09/01 00:54

Shanghai General Healthy Information and Technology (SHSE:605186) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥109.9m (down 4.9% from 2Q 2023).
  • Net income: CN¥24.3m (down 47% from 2Q 2023).
  • Profit margin: 22% (down from 40% in 2Q 2023).
  • EPS: CN¥0.18 (down from CN¥0.35 in 2Q 2023).
earnings-and-revenue-growth
SHSE:605186 Earnings and Revenue Growth September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Shanghai General Healthy Information and Technology Earnings Insights

Looking ahead, revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Medical Equipment industry in China.

Performance of the Chinese Medical Equipment industry.

The company's shares are up 4.1% from a week ago.

Risk Analysis

Before you take the next step you should know about the 2 warning signs for Shanghai General Healthy Information and Technology that we have uncovered.